> Conclusions Among outpatients with mild to moderate COVID-19, treatment with ivermectin, with a maximum targeted dose of 600 μg/kg daily for 6 days, compared

> Conclusions Among outpatients with mild to moderate COVID-19, treatment with ivermectin, with a maximum targeted dose of 600 μg/kg daily for 6 days, compared with placebo did not improve time to recovery. These findings do not support the use of ivermectin in patients with mild to moderate COVID-19. Actually, this is a flawed conclusion. A placebo, by definition, can have an effect. Therefore, no treatment at all - which they had no control for - is not the same as getting a placebo. Ivermectin and placebo might be about equal, but that doesn't mean no treatment at is just as good.